.OS Therapies are going to detail on the NYSE American stock substitution this morning using a $6.4 ...
.ALX Oncology's stage 2 gastric cancer reaction fee has compromised. After viewing its CD47 blocker ...
.An Additional of Ionis Pharmaceuticals' crucial midphase readouts has actually fallen short of assu...
.While Biogen's pharma peers are hunting for late-stage properties with little bit of danger, chief ...
.Instil Bio has actually been actually a biotech seeking a pipeline after it ditched its lead posses...
.Biogen has returned civil liberties to a very early Alzheimer's disease system to Denali Therapies,...
.Welcome to today's Chutes & Ladders, our summary of substantial leadership hirings, firings and ...
.Tip's attempt to address an unusual hereditary disease has actually reached an additional trouble. ...
.Vir Biotechnology's second-quarter incomes record had not been short of large headlines. The firm w...
.Galapagos has paused application in a test of a BCMA-directed CAR-T cell therapy, pushing the brake...